InvestorsHub Logo
Followers 24
Posts 287
Boards Moderated 0
Alias Born 03/21/2013

Re: ppnlf post# 12928

Monday, 05/11/2015 12:30:32 PM

Monday, May 11, 2015 12:30:32 PM

Post# of 40492
I was not a fan of the rs, and I am no fan of dilutions. Given the industry, I am at a loss to see how a "professional" could do much better. J Kim is about as good as you will get anywhere. Dr. Weiner, someone who would know told me years ago J. Kim was the best biotech Ceo he had ever met. Many others in the industry agree.

He is far from perfect, but he is exceptional in every way. I have spent many hours telling him he is wrong about some of his decisions, and he has listened to the criticism from myself and others. Sometimes I am even right. My point in bringing this up is that he is not out of touch, he listens to opposing points of view and even cultivates them. He just has a longer timeframe then most people. On top of that his first priority is keeping Ino in business and that is achieved by cash first.

He has a Wharton mba which is one of the definitions of professional. He kept ino/vgx in business through multiple failures early on. Well over 90% of small biotechs fold with a single failure. I think you do not realize the full depth of J Kim and how lucky we all are he is running this operation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News